Novel hydrazine derivatives as selective DPP-IV inhibitors: findings from virtual screening and validation through molecular dynamics simulations.

about

Novel hydrazine derivatives as selective DPP-IV inhibitors: findings from virtual screening and validation through molecular dynamics simulations.

Item

http://www.wikidata.org/entity/Q38398676

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Novel hydrazine derivatives as ...... olecular dynamics simulations.

@en

type

Item

label

Novel hydrazine derivatives as ...... olecular dynamics simulations.

@en

prefLabel

Novel hydrazine derivatives as ...... olecular dynamics simulations.

@en

P1476

Novel hydrazine derivatives as ...... molecular dynamics simulations

@en

P2093

Gautam Kumar

http://www.w3.org/2001/XMLSchema#string

Lalima Tanwar

http://www.w3.org/2001/XMLSchema#string

Mumtaz Alam

http://www.w3.org/2001/XMLSchema#string

Omprakash Tanwar

http://www.w3.org/2001/XMLSchema#string

Shaquiquzzaman

http://www.w3.org/2001/XMLSchema#string

Sridhara Janardhan

http://www.w3.org/2001/XMLSchema#string

P2860

Discovery of alogliptin: a potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV

A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy

Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Improved protein-ligand docking using GOLD

Vildagliptin: an inhibitor of dipeptidyl peptidase-4 with antidiabetic properties.

Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9.

Adverse effects of dipeptidyl peptidases 8 and 9 inhibition in rodents revisited.

P2888

s00894-014-2118-7

P304

2118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00894-014-2118-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Girdhar S Deora

Mymoona Akhter

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261256915

http://www.w3.org/2001/XMLSchema#string

P698

24687332

http://www.w3.org/2001/XMLSchema#string